Weighted Average Number of Shares Outstanding, Diluted of OCULAR THERAPEUTIX, INC from 31 Mar 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
OCULAR THERAPEUTIX, INC quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Mar 2018 to 31 Dec 2025.
  • OCULAR THERAPEUTIX, INC Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Dec 2025 was 187,241,483, a 18% increase year-over-year.
  • OCULAR THERAPEUTIX, INC annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 187,241,483, a 18% increase from 2024.
  • OCULAR THERAPEUTIX, INC annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 158,265,162, a 85% increase from 2023.
  • OCULAR THERAPEUTIX, INC annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 85,596,594, a 3.6% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

OCULAR THERAPEUTIX, INC Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 187,241,483 +28,976,321 +18% 01 Oct 2025 31 Dec 2025 10-K 05 Feb 2026 2025 FY
Q3 2025 183,919,808 +16,927,073 +10% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 172,594,662 +6,769,884 +4.1% 01 Apr 2025 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 169,396,989 +37,375,044 +28% 01 Jan 2025 31 Mar 2025 10-Q 05 May 2025 2025 Q1
Q4 2024 158,265,162 +72,668,568 +85% 01 Oct 2024 31 Dec 2024 10-K 05 Feb 2026 2025 FY
Q3 2024 166,992,735 +81,850,231 +96% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025 2025 Q3
Q2 2024 165,824,778 +87,777,073 +112% 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2025 2025 Q2
Q1 2024 132,021,945 +54,635,658 +71% 01 Jan 2024 31 Mar 2024 10-Q 05 May 2025 2025 Q1
Q4 2023 85,596,594 +2,952,327 +3.6% 01 Oct 2023 31 Dec 2023 10-K 05 Feb 2026 2025 FY
Q3 2023 85,142,504 +8,166,665 +11% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 78,047,705 -4,485,823 -5.4% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 77,386,287 -5,128,608 -6.2% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 82,644,267 +482,165 +0.59% 01 Oct 2022 31 Dec 2022 10-K 03 Mar 2025 2024 FY
Q3 2022 76,975,839 -8,471,047 -9.9% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023 2023 Q3
Q2 2022 82,533,528 +439,929 +0.54% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023 2023 Q2
Q1 2022 82,514,895 -4,730,811 -5.4% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q1
Q4 2021 82,162,102 +21,409,877 +35% 01 Oct 2021 31 Dec 2021 10-K 11 Mar 2024 2023 FY
Q3 2021 85,446,886 +16,685,096 +24% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022 2022 Q3
Q2 2021 82,093,599 +24,725,307 +43% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022 2022 Q2
Q1 2021 87,245,706 +35,344,824 +68% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q4 2020 60,752,225 01 Oct 2020 31 Dec 2020 10-K 06 Mar 2023 2022 FY
Q3 2020 68,761,790 +16,048,022 +30% 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021 2021 Q3
Q2 2020 57,368,292 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021 2021 Q2
Q1 2020 51,900,882 +7,726,513 +17% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q3 2019 52,713,768 +13,695,846 +35% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2020 Q3
Q1 2019 44,174,369 +9,381,521 +27% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q3 2018 39,017,922 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q1 2018 34,792,848 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q1

OCULAR THERAPEUTIX, INC Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 187,241,483 +28,976,321 +18% 01 Jan 2025 31 Dec 2025 10-K 05 Feb 2026 2025 FY
2024 158,265,162 +72,668,568 +85% 01 Jan 2024 31 Dec 2024 10-K 05 Feb 2026 2025 FY
2023 85,596,594 +2,952,327 +3.6% 01 Jan 2023 31 Dec 2023 10-K 05 Feb 2026 2025 FY
2022 82,644,267 +482,165 +0.59% 01 Jan 2022 31 Dec 2022 10-K 03 Mar 2025 2024 FY
2021 82,162,102 +21,409,877 +35% 01 Jan 2021 31 Dec 2021 10-K 11 Mar 2024 2023 FY
2020 60,752,225 +15,478,994 +34% 01 Jan 2020 31 Dec 2020 10-K 06 Mar 2023 2022 FY
2019 45,273,231 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.